Journal article
Enzymatic Antibody Tagging: Toward a Universal Biocompatible Targeting Tool
HT Ta, K Peter, CE Hagemeyer
Trends in Cardiovascular Medicine | ELSEVIER SCIENCE LONDON | Published : 2012
Abstract
Targeted delivery or "smart delivery" of pharmaceutical or imaging agents and even entire cells such as stem cells is an emerging trend in modern biotechnology. A binding ligand such as an antibody that can specifically bind to receptors expressed at a disease site is an essential component of such constructs. Different chemical methods have been widely used to apply antibodies for delivery systems; however, they typically result in impairment or loss of antibody functionality. Enzyme-mediated conjugation approaches have been developed to overcome this major disadvantage of conventional chemical methods. Sortase, an enzyme derived from Staphylococcus aureus, is able to provide a biochemicall..
View full abstractGrants
Awarded by Australian Research Council
Funding Acknowledgements
H.T.T., K.P., and C.E.H. are supported by a National Heart Foundation Postdoctoral Fellowship (PF09M4688), an Australian Research Council Future Fellowship (FT0992210), and a National Health and Medical Research Council Career Development Fellowship (472668), respectively.